Baker RN, Broward JA, Fang HC, et al.
Anticoagulant
therapy in cerebral infarction: report on cooperative
study.
Neurology 1962;12:823-835.
Bath PM, Lindenstrom E, Boysen G, De Deyn P, Friis P,
Leys D, Marttila R, Olsson J, O'Neill D, Orgogozo J, Ringelstein
B, van der Sande J, Turpie AG.
Tinzaparin in acute ischaemic stroke (TAIST):
a randomised aspirin-controlled trial. Lancet.
2001 Sep 1;358(9283):702-10 Stroke Trials Directory Entry: TAIST
Berge E, Abdelnoor M, Nakstad PH, Sandset PM.
Low molecular-weight heparin versus aspirin
in patients with acute ischaemic stroke and atrial fibrillation:
a double-blind randomised study. HAEST Study Group. Heparin
in Acute Embolic Stroke Trial. Lancet
2000;355:1205 Stroke Trials Directory Entry: HAEST
Biller J, Bruno A, Adams HP Jr, Godersky JC, Loftus CM,
Mitchell VL, Banwart KJ, Jones MP.
A randomized trial of aspirin or heparin
in hospitalized patients with recent transient ischemic
attacks. A pilot study. Stroke.
1989 Apr;20(4):441-7
CAST (Chinese Acute Stroke Trial) Collaborative Group.
CAST: randomised placebo-controlled trial
of early aspirin use in 20,000 patients with acute ischaemic
stroke. Lancet.
1997 Jun 7;349(9066):1641-9 Stroke Trials Directory Entry:CAST
de Bruijn SF, Stam J.
Randomized, placebo-controlled trial of
anticoagulant treatment with low-molecular-weight heparin
for cerebral sinus thrombosis. Stroke.
1999 Mar;30(3):484-8
Diener HC, Ringelstein EB, von Kummer R, Langohr HD, Bewermeyer
H, Landgraf H, Hennerici M, Welzel D, Grave M, Brom J,
Weidinger G.
Treatment of acute ischemic stroke with
the low-molecular-weight heparin certoparin: results of
the TOPAS trial. Therapy of Patients With Acute Stroke
(TOPAS) Investigators. Stroke
2001;32:22 Stroke Trials Directory Entry: TOPAS
Einhaupl KM, Villringer A, Meister W, Mehraein S, Garner
C, Pellkofer M, Haberl RL, Pfister HW, Schmiedek P.
Heparin treatment in sinus venous thrombosis. Lancet.
1991 Sep 7;338(8767):597-600.
International Stroke Trial Collaborative Group.
The International Stroke Trial (IST): a
randomised trial of aspirin, subcutaneous heparin, both,
or neither among 19435 patients with acute ischaemic stroke. Lancet.
1997 May 31;349(9065):1569-81 Stroke Trials Directory Entry: IST
Kay R, Wong KS, Yu YL, Chan YW, Tsoi TH, Ahuja AT, Chan
FL, Fong KY, Law CB, Wong A.
Low-molecular-weight heparin for the treatment
of acute ischemic stroke. N
Engl J Med. 1995 Dec 14;333(24):1588-93.
Keith DS, Phillips SJ, Whisnant JP, Nishimaru K, O'Fallon
WM.
Heparin therapy for recent transient focal
cerebral ischemia. Mayo
Clin Proc. 1987 Dec;62(12):1101-6.
The Publications Committee for the Trial of ORG 10172
in Acute Stroke Treatment (TOAST) Investigators.
Low molecular weight heparinoid, ORG 10172
(danaparoid), and outcome after acute ischemic stroke:
a randomized controlled trial. JAMA.
1998 Apr 22-29;279(16):1265-72 Stroke Trials Directory Entry:TOAST
Fraxiparine in Ischemic Stroke Study (FISS).
7th European Stroke Conference. Edinburgh, United Kingdom,
May 27-30, 1998. Abstracts. Cerebrovasc
Dis 1998;8(Suppl 4):64 Stroke Trials Directory Entry:FISS
Fraxiparin in Ischemic Stroke Study
Presented at the European Stroke Conference (May 2005). Stroke Trials Directory Entry:FISS-tris
